Reviewed November 16, 2026

Devoted Health

Private
devoted.com

Medicare Advantage and integrated care

Company overview

Revenue
~$3.27B revenue
FY2024 · Estimate
Reference valuation
$25B
Series G · reported mark · Oct 2026
Primary customer
Eligible members[3]
Commercial model
Insurance premiums[3]

The company confirms the financing but does not disclose its valuation. The $25B mark and older revenue estimate come from third-party profiles; insurance revenue is not comparable to SaaS ARR.[1][2][3]

Members
466,000[3]
January 2026 · reported
Financial evidence
Revenue basis~$3.27B revenue · FY2024 · Estimate
Valuation basisSeries G · reported mark Oct 2026
Growth historyComparable revenue history is not established in this profile; no growth rate inferred.

Products, customers & revenue model

ProductCustomerCommercial model
Medicare Advantage[3]Eligible members

Insurance premiums

Integrated care[3]Plan members

Care delivery and member services

Business economics

What drives the business
Enrollment drives premiums, but claims and care costs determine underwriting economics.[3]

Leadership & functional coverage

Selected leaders supported by the linked sources; dated appointments retain their source context. This is not a complete org chart. Advisory roles are labeled.

LeaderRoleFunction / context
Ed ParkCofounder & CEOCompany leadership · October 2026 announcement[4]
Todd ParkCofounder & Executive ChairmanExecutive chair · October 2026 announcement[4]
Shannon O’KaneChief Compliance OfficerCompliance[5]
Neil WagleChief Medical OfficerClinical leadership · May 2026 speaker biography[6]

Dated financial disclosures

DateEvent
FY2024~$3.27B revenue[1][2][3]

Estimate. Revenue observation; separate from the financing date.

Oct 2026$25B reference valuation[1][2][3]

Series G · reported mark

Sector comparison

Same vertical; different business models and reporting periods. Values are not directly comparable revenue multiples.

CompanyRevenue measureReference valuation
Devoted Health~$3.27B revenue

FY2024

$25B

Oct 2026

OpenEvidence~$300M run rate

July 2026

$15B

Sep 2026

Ro~$3.02B run rate

October 2026

$7B

Feb 2022

Commure~$105M ARR

March 2024

$7B

May 2026

Abridge~$100M ARR

May 2025

$5.3B

Jun 2025

Open research questions

  • ↗Does membership expansion improve the medical cost ratio?

Sources & definitions

Financial history preserves the source’s measurement basis. ARR, annualized revenue, completed-year sales and transaction volume are distinct. Product economics are Plank analysis of the cited business model; open questions are not asserted findings.

  1. 1Devoted · financing announcement, October 1, 2026
  2. 2Caplight · reported Series G mark
  3. 3Sacra · company research and financial history
  4. 4Company · leadership directory or appointment
  5. 5Company · leadership directory or appointment
  6. 6Mass EQLHS · leadership webinar